| Stereochemistry | ABSOLUTE |
| Molecular Formula | C27H24N4O2S |
| Molecular Weight | 468.57 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O[C@@H]1CCN(CC2=CSC3=NC(=CN23)C4=C(NC(=O)C5=CC6=C(C=CC=C6)C=C5)C=CC=C4)C1
InChI
InChIKey=MUFSINOSQBMSLE-JOCHJYFZSA-N
InChI=1S/C27H24N4O2S/c32-22-11-12-30(15-22)14-21-17-34-27-29-25(16-31(21)27)23-7-3-4-8-24(23)28-26(33)20-10-9-18-5-1-2-6-19(18)13-20/h1-10,13,16-17,22,32H,11-12,14-15H2,(H,28,33)/t22-/m1/s1
| Molecular Formula | C27H24N4O2S |
| Molecular Weight | 468.57 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 360.0 nM [EC50] |
